Conference - London, United Kingdom
Nearing a decade of the EU Paediatric Regulation, with close to 2,000 submitted Paediatric Investigation Plans (PIPs), paediatric needs are recognised as an integrated part of drug development, with the inclusion of children now accepted as standard procedure. However, challenges remain, which can result in delayed access by children to innovative medicines. This year’s DIA/EFGCP/EMA annual paediatric conference will focus on ways to overcome these challenges, such as through collaboration, extrapolation, modelling and simulation and adaptive pathways. This is the conference to interact with EMA paediatric coordinators, Paediatric Committee (PDCO) members and other stakeholders interested in paediatric drug development. Patients’ and Healthcare professional’s views will complement the reports of practical experience. In addition you have the possibility to send your question already beforehand to be sure that the topic will be addressed during the conference.
- Organization: DIA EMEA
Thu, Oct 01, 2015 - Fri, Oct 02, 2015
Hilton London Docklands Riverside
265 Rotherhithe Street, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.